Bcrx stock history xhllquz

Bcrx stock history

27.02.2021

Noman58107

BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor, for the treatment of acute uncomplicated influenza under the RAPIVAB, ALPIVAB, RAPIACTA, and PERAMIFLU names; and Mundesine, an oral purine nucleoside phosphorylase inhibitor for peripheral T-cell lymphoma. Biocryst Pharmaceuticals Inc. BCRX - Quotes, Financials ... Stocks Rankings for BCRX. U.S. News compares companies to their industry peers based on a variety of company fundamentals, performance metrics and investor preferences to help you find the right BCRX Stock | BIOCRYST PHARMACEUTICALS Stock Price Today ... BCRX: Get the latest BioCryst Pharmaceuticals stock price and detailed information including BCRX news, historical charts and realtime prices. BCRX Historical Stock Prices BioCryst Pharmaceuticals (BCRX) has the following price history information. Looking back at BCRX historical stock prices for the last five trading days, on March 13, 2020, BCRX opened at $2.28, traded as high as $2.28 and as low as $1.86, and closed at $2.21. Trading volume was a total of 8.20M shares.

BCRX Dividend History & Description — BioCryst Pharmaceuticals Inc. BioCryst Pharmaceuticals is a biotechnology company that discovers oral, small-molecule medicines. Co. focuses on oral treatments for rare diseases.

BCRX Insider Trading Activity (BioCryst Pharmaceuticals) Which company executives are buying and selling shares of BioCryst Pharmaceuticals (NASDAQ:BCRX) stock? View the most recent insider trading activity for BCRX stock at MarketBeat. BCRX Stock Quote of Biocryst Pharma Inc - InvestorPlace Check out our BCRX stock analysis, current BCRX quote, charts, and historical prices for Biocryst Pharma Inc stock

BioCryst Pharmaceuticals Stock Price History + Charts (BCRX)

BioCryst Pharmaceuticals, Inc Stock Chart and Share Price Forecast, Short-Term "BCRX" Stock Prediction Get breaking news and analysis on BioCryst Pharmaceuticals, Inc. (BCRX) stock, price quote and chart, trading and investing tools. Stock Analysis, Dividends, Split History. BCRX / BioCryst Pharmaceuticals, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio,

19 Mar 2020 The BCRX stock was last observed hovering at around $1.82 in the last trading session, with the day's loss setting it -0.22% off its average

Find the latest BioCryst Pharmaceuticals, Inc. (BCRX) stock quote, history, news and other vital information to help you with your stock trading and investing. BioCryst Pharmaceuticals, Inc. (BCRX) Stock Historical ... 102 rows · Discover historical prices for BCRX stock on Yahoo Finance. View daily, weekly or monthly … BioCryst Pharmaceuticals, Inc. Common Stock (BCRX ... Find the latest dividend history for BioCryst Pharmaceuticals, Inc. Common Stock (BCRX) at Nasdaq.com.

BCRX Stock Summary. Of note is the ratio of Biocryst Pharmaceuticals Inc's sales and general administrative expense to its total operating expenses; merely 12.98% of US stocks have a lower such ratio. BCRX's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 99.59% of US stocks.